罗马IV功能性肠病症状患者结肠镜检查的诊断率
这项前瞻性研究纳入2019年646例符合罗马IV功能性肠病症状并接受门诊结肠镜检查的成人,评估有机疾病诊断率。有机疾病总患病率为12%,腹泻型 disorders 高于便秘型(约17% vs 约6%,p=.005),差异主要由显微镜性结肠炎解释(5.7% vs 0%,p<.001)。无警报特征者仅11例(2%),结肠镜检查均正常。
要点
- 646例功能性肠病症状患者中98%有警报特征,有机疾病总患病率为12%。
- 腹泻型 disorders 有机疾病患病率约17%,高于便秘型的约6%(p=.005)。
- 显微镜性结肠炎在腹泻型为5.7%,便秘型为0%(p<.001),但1/4慢性腹泻患者未取结肠活检。
核心结论
- 多数因功能性肠病症状转诊结肠镜的患者有警报特征;腹泻型 disorders 的有机疾病患病率显著高于便秘型,显微镜性结肠炎 largely 解释该差异且为漏诊诊断机会;无警报特征者结肠镜诊断率为零。
研究设计与样本
- 前瞻性研究,2019年连续纳入符合罗马IV功能性肠病症状并接受门诊结肠镜检查的成人,收集人口学、警报特征及肠道症状问卷,内镜医师对问卷数据设盲。
- 有机疾病定义为炎症性肠病、结直肠癌或显微镜性结肠炎。
- 共646例患者符合罗马IV功能性肠病症状标准:肠易激综合征(IBS)56%、功能性腹泻27%、功能性便秘17%。
主要发现
- 几乎全部患者(98%)有警报特征;有机疾病总患病率为12%。
- 有机疾病患病率在功能性便秘和IBS-便秘型均约6%,IBS-混合型约9%,功能性腹泻和IBS-腹泻型均约17%(p=.005)。
- 腹泻型 vs 便秘型 disorders 的显微镜性结肠炎患病率为5.7% vs 0%(p<.001),炎症性肠病为7.2% vs 4.0%(p=.2),结直肠癌为4.2% vs 2.3%(p=.2)。
- 1/4慢性腹泻患者( conceivably 有显微镜性结肠炎风险)未取结肠活检。
- 646例中仅11例(2%)无警报特征,其结肠镜检查均正常。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: There is little data on the diagnostic yield of colonoscopy in patients with symptoms compatible with functional bowel disorders (FBDs). Previous studies have only focused on diagnostic outcomes of colonoscopy in those with suspected irritable bowel syndrome using historic Rome I-III criteria, whilst having partially assessed for alarm features and shown markedly conflicting results. There is also no colonoscopy outcome data for other FBDs, such as functional constipation or functional diarrhea. Using the contemporaneous Rome IV criteria we determined the diagnostic yield of colonoscopy in patients with symptoms compatible with a FBD, stratified diligently according to the presence or absence of alarm features. METHODS: Basic demographics, alarm features, and bowel symptoms using the Rome IV diagnostic questionnaire were collected prospectively from adults attending out-patient colonoscopy in 2019. Endoscopists were blinded to the questionnaire data. Organic disease was defined as the presence of inflammatory bowel disease, colorectal cancer, or microscopic colitis. RESULTS: 646 patients fulfilled symptom-based criteria for the following Rome IV FBDs: IBS (56%), functional diarrhea (27%) and functional constipation (17%). Almost all had alarm features (98%). The combined prevalence of organic disease was 12%, being lowest for functional constipation and IBS-constipation (∼6% each), followed by IBS-mixed (∼9%), and highest amongst functional diarrhea and IBS-diarrhea (∼17% each); p = .005. The increased prevalence of organic disease in diarrheal versus constipation disorders was accounted for by microscopic colitis (5.7% vs. 0%, p < .001) but not inflammatory bowel disease (7.2% vs. 4.0%, p = .2) or colorectal cancer (4.2% vs. 2.3%, p = .2). However, 1-in-4 chronic diarrhea patients - conceivably at risk for microscopic colitis - did not have colonic biopsies taken. Finally, only 11 of 646 (2%) patients were without alarm features, in whom colonoscopy was normal. CONCLUSIONS: Most patients with symptoms of FBDs who are referred for colonoscopy have alarm features. The presence of organic disease is significantly higher in diarrheal versus constipation disorders, with microscopic colitis largely accounting for the difference whilst also being a missed diagnostic opportunity. In those patients without alarm features, the diagnostic yield of colonoscopy was nil.
引用
- Asghar Z, Thoufeeq M, Kurien M, et al. Diagnostic Yield of Colonoscopy in Patients With Symptoms Compatible With Rome IV Functional Bowel Disorders. Clin Gastroenterol Hepatol. 2020. PMID: 32882424. doi:10.1016/j.cgh.2020.08.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。